Skip to main content
NeutriSci International Inc. logo

NeutriSci International Inc. — Investor Relations & Filings

Ticker · NU.H ISIN · CA64129Y1079 LEI · 549300V2XEUV74YJRV42 TSXV Manufacturing
Open in API
Filings indexed 89 across all filing types
Latest filing 2024-05-04 Delisting Announcement
Country CA Canada
Listing TSXV NU.H

About NeutriSci International Inc.

https://neutrisci.com/

NeutriSci International Inc. is a specialist in the innovation, production, and formulation of nutraceutical products, focusing primarily on the business-to-business (B2B) sector. The company also develops and produces formulations for the CBD/THC industries. NeutriSci utilizes proprietary intellectual property, including its patent-pending Cryolization Technology, to engineer products that ensure the rapid and efficient systemic delivery of active ingredients. By integrating natural components, NeutriSci provides B2B partners with comprehensive expertise in product development and formulation, facilitating the creation of finished goods for international distribution. The company is actively expanding its global B2B network across markets in Europe, Asia, South America, and Australia.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Delisting Announcement Classification · 95% confidence The document is a short announcement (3127 characters) about NeutriSci International Inc. transferring its stock listing from the TSX Venture Exchange to the NEX Board due to not meeting continued listing requirements. It includes details about the change in trading symbol and the company's plans to restructure and recapitalize. There are no financial statements, detailed financial data, or comprehensive reports included. The document is clearly an official notice about a change in listing status, which fits the definition of a Delisting Announcement (DLST) since the company is being moved to a different trading board due to non-compliance with listing criteria. The document is not a full report, earnings release, or regulatory filing of another type. Therefore, the correct classification is DLST with high confidence.
2024-05-04 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate signed by the CEO certifying the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2023. It explicitly states it is a certification related to interim filings, not the filings themselves. The document is short (3013 characters) and primarily an officer certification letter. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report (IR) itself, since it does not contain substantive financial data or analysis but only certifies the filings.
2023-11-24 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a Form 52-109FV2 Certification of Interim Filings Venture Issuer Basic Certificate by the CFO of NeutriSci International Inc. It certifies the review and fair presentation of the interim financial report and interim MD&A for the period ended September 30, 2023. The document is a certification letter and does not contain actual financial data or the interim report itself. It explicitly states it is a certification and notes differences from non-venture issuer certifications. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS), not as the interim report (IR) itself.
2023-11-24 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Condensed Consolidated Interim Financial Statements (Unaudited - Prepared by Management)' and includes detailed financial statements such as Statements of Financial Position, Statements of Loss and Comprehensive Loss, Statements of Changes in Shareholders' Deficiency, and Statements of Cash Flows for the three and nine months ended September 30, 2023 and 2022. It explicitly states it is unaudited and prepared by management, and it includes substantive financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). The document length is substantial (15,000 characters), and it contains actual financial statements, not just an announcement or certification. Therefore, the correct classification is IR with high confidence.
2023-11-24 English
Interim MD&A - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Management's Discussion and Analysis for the three and nine months ended September 30, 2023,' indicating it is an MD&A report. It contains detailed financial results and analysis for the three and nine months ended September 30, 2023, including revenue, expenses, net loss, and comprehensive loss figures. The document references interim financial statements prepared under IFRS and discusses operational results, outlook, and risks. The length is substantial (15,000 characters), and it contains substantive financial data and management commentary. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year with actual financial statements and analysis. It is not a mere announcement or certification, nor is it a full annual report. Therefore, the correct classification is IR with high confidence.
2023-11-24 English
News release - English.pdf
Capital/Financing Update Classification · 100% confidence The document is titled as a "Prospectus" for an Initial Public Offering (IPO) of shares by Sucro Limited dated October 19, 2023. It contains detailed information about the offering price, number of shares, underwriting arrangements, share capital structure, and legal disclaimers typical of a prospectus used in capital raising. There is no indication that this is a report of financial results, management discussion, or regulatory filing unrelated to capital raising. The document is not an announcement of a report but the actual offering document itself. Therefore, it fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPO prospectuses.
2023-10-20 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.